FindTrial
Sign In

Establish a system for rapid prediction of drug sensitivity of drug-resistant bacteria in the respiratory tract

Development and clinical Application of a rapid prediction system for drug sensitivity of respiratory drug-resistant bacteria Based on flight mass spectrometry and artificial intelligence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116572
Enrollment
Unknown
Registered
2026-01-12
Start date
2026-01-16
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Observation group:None

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa or Staphylococcus aureus isolated from clinical samples. 2.Strains from other hospitals are required to have drug sensitivity information and a mass spectrometry score greater than 2.0 points. 3.The patient is over 18 years old.

Exclusion criteria

Exclusion criteria: 1.The strains from other hospitals have no drug sensitivity information or the mass spectrometry score is less than 2.0.

Design outcomes

Primary

MeasureTime frame
Accuracy of prediciton;—

Countries

China

Contacts

Public ContactJiankang Zhao

China-Japan Friendship Hospital

zjk4265296@163.com+86 10 8420 6256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026